JANUET 50/850 MG TABLETS

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Dostupno od:

MERCK SHARP & DOHME ISRAEL LTD

ATC koda:

A10BA02

Farmaceutski oblik:

TABLETS

Administracija rute:

PER OS

Proizveden od:

MERCK SHARP & DOHME CORP., USA

Terapijska grupa:

METFORMIN

Terapijske indikacije:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Datum autorizacije:

2008-12-01